Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial (Q73365339)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11145489%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11145489%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

placebo-controlled trial

1 reference

inferred from title

author name string

ESPRIT Investigators. Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin Therapy

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11145489%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 December 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11145489%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11145489%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

356

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11145489%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

9247

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11145489%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

2037-2044

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11145489%20AND%20SRC:MED&resulttype=core&format=json

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903400-0

7 January 2021

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903400-0

7 January 2021

Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903400-0

7 January 2021

Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker Integrelin in elective coronary intervention. IMPACT Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903400-0

7 January 2021

Immediate and reversible platelet inhibition after intravenous administration of a peptide glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903400-0

7 January 2021

Effect of Ca2+ on GP IIb-IIIa interactions with integrilin: enhanced GP IIb-IIIa binding and inhibition of platelet aggregation by reductions in the concentration of ionized calcium in plasma anticoagulated with citrate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903400-0

7 January 2021

Pharmacodynamic study of F(ab')2 fragments of murine monoclonal antibody 7E3 directed against human platelet glycoprotein IIb/IIIa in patients with unstable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903400-0

7 January 2021

Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903400-0

7 January 2021

Design and methodology of the ESPRIT trial: evaluating a novel dosing regimen of eptifibatide in percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903400-0

7 January 2021

Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903400-0

7 January 2021

Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903400-0

7 January 2021

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903400-0

7 January 2021

Stenting for ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903400-0

7 January 2021

Improved clinical outcome after widespread use of coronary-artery stenting in Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903400-0

7 January 2021

Myonecrosis after revascularization procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903400-0

7 January 2021

The myth of the myocardial 'infarctlet' during percutaneous coronary revascularization procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903400-0

7 January 2021

Economic issues in glycoprotein IIb/IIIa receptor therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903400-0

7 January 2021

Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903400-0

7 January 2021

Acute profound thrombocytopenia after C7E3 Fab (abciximab) therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903400-0

7 January 2021

10.1016/S0140-6736(00)03400-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11145489%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference